Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23). McCracken M, Walkty A, Adam HJ, Baxter M, et al. J Antimicrob Chemother 2025;80.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCracken M, Walkty A, Adam HJ, Baxter M, et al. Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23). J Antimicrob Chemother 2025;80.
PMID: 40873031